Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy (Q39785729)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2007

Language	Label	Description	Also known as
English	Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy	scientific article published on February 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dawn L. Hershman

1

object named as

Dawn Hershman

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Alfred I. Neugut

2

object named as

Alfred I Neugut

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Judith S Jacobson

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Jian Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Wei-Yann Tsai

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Russell McBride

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Charles L Bennett

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Victor R Grann

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

196-205

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidence

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Lineage-specific hematopoietic growth factors

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Does the concurrent use of anthracycline and granulocyte colony-stimulating factor influence the risk of secondary leukaemia in breast cancer women?

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Development of a comorbidity index using physician claims data

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Comorbidity and functional status are independent in older cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Two different classes of therapy-related and de-novo acute myeloid leukemia?

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

The colony stimulating factors. Discovery, development, and clinical applications

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Growth Curve of an Experimental Solid Tumor Following Radiotherapy

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Predicting the course of Gompertzian growth

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Outpatient gatifloxacin therapy and dysglycemia in older adults

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Scientific publishing. Echoing other cases, NEJM says Vioxx Safety data withheld

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

The lessons of Vioxx--drug safety and sales

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Postmarketing surveillance for drug safety: surely we can do better

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Oral erythromycin and the risk of sudden death from cardiac causes

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK028

21 January 2018

Identifiers

10.1093/JNCI/DJK028

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39785729&oldid=2090358811"